SLAMF7 (CD319/CS1) Is Expressed in Plasmablastic Lymphoma and Is a Potential Diagnostic Marker and Therapeutic Target

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15393
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

BRG1 Is a Prognostic Marker and Potential Therapeutic Target in Human Breast Cancer

PLoS ONE
Multidisciplinary
2013English

Aminoacylase 3 Is a New Potential Marker and Therapeutic Target in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2018English

CD83 Is a New Potential Biomarker and Therapeutic Target for Hodgkin Lymphoma

Haematologica
Hematology
2018English

Annexin A8 Is a Prognostic Marker and Potential Therapeutic Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2015English

B7-H3, a Potential Therapeutic Target, Is Expressed in Diffuse Intrinsic Pontine Glioma

Journal of Neuro-Oncology
Cancer ResearchOncologyNeurology
2012English

Calnexin, an ER-induced Protein, Is a Prognostic Marker and Potential Therapeutic Target in Colorectal Cancer

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2016English

CD200 Is Induced by ERK and Is a Potential Therapeutic Target in Melanoma

Journal of Clinical Investigation
Medicine
2007English

MERTK Is a Potential Therapeutic Target in Malignant Melanoma

Cancer Discovery
Oncology
2013English

Kir3dl2 Is Expressed in Peripheral T-Cell Lymphomas and May Be a Therapeutic Target

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy